Healthy adults
Conditions
Interventions
Inhalation of aqueous ClO2 aerosol to the volunteer, for 12 weeks (not less than 4 hours a week).
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy male/female adults. (2) Expected person working at the CPCC Company office for not less than four hours a week. (3) Volunteers who gave informed consent to take part in this trial after being provided with an explanation of our experimental protocol detail.
Exclusion criteria
Exclusion criteria: (1) Volunteers who are now under the other clinical tests with some kind of medicine and/or health food, or took part in those tests within four weeks after the current trial. (2) Volunteers with current and/or previous medical history of serious diseases in respiratory system. (3) Volunteers who donated their blood components and/or whole blood (200 mL) within a month to this trial. (4) Males who donated their whole blood (400 mL) within the last three months to this trial. (5) Females who donated their whole blood (400 mL) within the last four months to this trial. (6) Males who will be collected in total of their blood (1200 mL) within the last twelve months, after adding the blood amounts planning to be sampled in this trial. (7) Females who will be collected in total of their blood (800 mL) within the last twelve months, after adding the blood amounts planning to be sampled in this trial. (8) Others who have been determined as ineligible for participation in this trial, according to the principal/sub investigator's opinions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events, and incidence rate of side effects | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Body weight 2. Subjective symptoms 3. Hematologic test (WBC) 4. Blood-biochemical test (AST, ALT, gamma-GTP) 5. Immunological test (CRP) | — |
Countries
Japan
Contacts
Public ContactMitsuhiro Fujimoto
CPCC Company Limited Planning & Sales Department
Outcome results
None listed